BioCentury
ARTICLE | Clinical News

Sulfur hexafluoride lipid-type A microspheres regulatory update

October 20, 2014 7:00 AM UTC

FDA approved Lumason sulfur hexafluoride lipid-type A microspheres from Bracco as an ultrasound contrast agent. The product is indicated for use in adults with suboptimal echocardiograms to opacify th...